Review article · 2004

The IKK NF-κB system: a treasure trove for drug development

Michael Karin, Yumi Yamamoto, Q May Wang

Nature Reviews Drug Discovery, 3(1), 17–26 · Published 1 January 2004 · DOI 10.1038/nrd1279

View at the publisherCite this paper

In brief

“The IKK NF-κB system: a treasure trove for drug development” is a 2004 review article by Michael Karin and 2 co-authors, published in Nature Reviews Drug Discovery. OpenAlex counts 1,386 citations as of 15 November 2026, which puts it in the top 1% of works published in 2004 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
1,386
Most cited in
2020 (51)
Field-weighted impact
10.79
References
73
Authors
3

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Karin, M., Yamamoto, Y., & Wang, Q. M. (2004). The IKK NF-κB system: a treasure trove for drug development. Nature Reviews Drug Discovery, 3(1), 17–26. https://doi.org/10.1038/nrd1279

MLA 9

Karin, Michael, et al. “The IKK NF-κB system: a treasure trove for drug development.” Nature Reviews Drug Discovery, vol. 3, no. 1, 2004, pp. 17–26. https://doi.org/10.1038/nrd1279.

Chicago

Karin, Michael, Yumi Yamamoto, and Q May Wang. 2004. “The IKK NF-κB system: a treasure trove for drug development.” Nature Reviews Drug Discovery 3 (1): 17–26. https://doi.org/10.1038/nrd1279.

Harvard

Karin, M., Yamamoto, Y. and Wang, Q. M. (2004) ‘The IKK NF-κB system: a treasure trove for drug development’, Nature Reviews Drug Discovery, 3(1), pp. 17–26. doi:10.1038/nrd1279.

IEEE

M. Karin, Y. Yamamoto, and Q. M. Wang, “The IKK NF-κB system: a treasure trove for drug development,” Nature Reviews Drug Discovery, vol. 3, no. 1, pp. 17–26, 2004, doi: 10.1038/nrd1279.

BibTeX

@article{karin2004system,
  title     = {{The IKK NF-κB system: a treasure trove for drug development}},
  author    = {Karin, Michael and Yamamoto, Yumi and Wang, Q May},
  journal   = {Nature Reviews Drug Discovery},
  year      = {2004},
  volume    = {3},
  number    = {1},
  pages     = {17--26},
  doi       = {10.1038/nrd1279},
  url       = {https://doi.org/10.1038/nrd1279}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
20174343
20184343
20193838
20205151
20213838
20223535
20233434
20242929
20251515
20261818

Its field-weighted citation impact is 10.79: it has been cited 10.79 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways

  • NF-κB
  • Rel transcription factors
  • IκB kinase
  • NF-κB inhibitors
  • drug development
  • inflammation
  • autoimmune disease
  • cancer

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Karin, M., Yamamoto, Y., & Wang, Q. M. (2004). The IKK NF-κB system: a treasure trove for drug development. Nature Reviews Drug Discovery, 3(1), 17–26. https://doi.org/10.1038/nrd1279

How many times has this paper been cited?

1,386 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Michael Karin, Yumi Yamamoto, Q May Wang.

What is the DOI of this paper?

10.1038/nrd1279. The permanent link is https://doi.org/10.1038/nrd1279.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.